AMGEN INC

Insider Reports History

Location
Thousand Oaks, CA
Signature
/s/ Peter H. Griffith, Executive Vice President and Chief Financial Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by AMGEN INC:

Company Role Class Num Shares Value Price $ Report Date Ownership
BeiGene, Ltd. 10%+ Owner American Depositary Shares 18,943,802 $3,419,356,261 $180.50 10 Sep 2021 Direct
Neumora Therapeutics, Inc. 10%+ Owner Common Stock 35,368,653 $423,716,463 $11.98 19 Sep 2023 Direct
Vigil Neuroscience, Inc. 10%+ Owner Common Stock 3,206,281 $12,023,554 $3.75 11 Jan 2022 Direct
Neumora Therapeutics, Inc. 10%+ Owner Series A-2 Preferred Stock 0 19 Sep 2023 Direct
Neumora Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 19 Sep 2023 Direct
Vigil Neuroscience, Inc. 10%+ Owner Series A Preferred Stock 0 11 Jan 2022 Direct

Insider Reports Filed by AMGEN INC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NMRA Neumora Therapeutics, Inc. 19 Sep 2023 4 +$29,999,985 4 10%+ Owner 19 Sep 2023, 19:52
NMRA Neumora Therapeutics, Inc. 14 Sep 2023 0 $0 3 10%+ Owner 14 Sep 2023, 18:58
VIGL Vigil Neuroscience, Inc. 11 Jan 2022 2 $0 4 10%+ Owner 11 Jan 2022, 20:33
VIGL Vigil Neuroscience, Inc. 06 Jan 2022 0 $0 3 10%+ Owner 06 Jan 2022, 19:39
BGNE BeiGene, Ltd. 10 Sep 2021 1 +$49,999,938 4 10%+ Owner 13 Sep 2021, 19:27